Old National Bancorp Cerus Corp Transaction History

Old National Bancorp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 17, 2023	SELL	$1.5 - $3.07 $73,500 - $150,430	-49,000 Reduced 58.29%	35,067 $56,000
Q4 2022 Feb 03, 2023	SELL	$3.38 - $4.22 $557,879 - $696,523	-165,053 Reduced 66.25%	84,067 $307,000
Q3 2022 Feb 17, 2023	BUY	$3.43 - $5.83 $566,131 - $962,258	165,053 Added 196.34%	249,120 $897,000
Q3 2022 Nov 08, 2022	SELL	$3.43 - $5.83 $23,543 - $40,017	-6,864 Reduced 2.68%	249,120 $897,000
Q2 2022 Jul 25, 2022	BUY	$4.41 - $5.69 $1.13 Million - $1.46 Million	255,984 New	255,984 $1.35 Million

156

148M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.